ALDH5A1 (aldehyde dehydrogenase 5 family member A1)

2018-07-01  

Identity

HGNC
LOCATION
6p22.3
LOCUSID
ALIAS
SSADH,SSDH
FUSION GENES

Other Information

Locus ID:

NCBI: 7915
MIM: 610045
HGNC: 408
Ensembl: ENSG00000112294

Variants:

dbSNP: 7915
ClinVar: 7915
TCGA: ENSG00000112294
COSMIC: ALDH5A1

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000112294ENST00000348925P51649
ENSG00000112294ENST00000348925X5D299
ENSG00000112294ENST00000357578P51649
ENSG00000112294ENST00000357578X5DQN2
ENSG00000112294ENST00000491546C9J8Q5

Expression (GTEx)

0
5
10
15
20
25
30
35
40
45
50

Pathways

PathwaySourceExternal ID
Butanoate metabolismKEGGko00650
Butanoate metabolismKEGGhsa00650
Alanine, aspartate and glutamate metabolismKEGGko00250
Alanine, aspartate and glutamate metabolismKEGGhsa00250
Metabolic pathwaysKEGGhsa01100
GABA (gamma-Aminobutyrate) shuntKEGGhsa_M00027
GABA (gamma-Aminobutyrate) shuntKEGGM00027
Neuronal SystemREACTOMER-HSA-112316
Transmission across Chemical SynapsesREACTOMER-HSA-112315
Neurotransmitter Release CycleREACTOMER-HSA-112310
GABA synthesis, release, reuptake and degradationREACTOMER-HSA-888590
Degradation of GABAREACTOMER-HSA-916853

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA445043Opioid-Related DisordersDiseaseClinicalAnnotationassociatedPD24230997
PA450401methadoneChemicalClinicalAnnotationassociatedPD24230997
PA451846valproic acidChemicalPathwayassociated23407051

References

Pubmed IDYearTitleCitations
381100412024ALDH5A1-deficient iPSC-derived excitatory and inhibitory neurons display cell type specific alterations.2
386588502024Clinical and molecular outcomes from the 5-Year natural history study of SSADH Deficiency, a model metabolic neurodevelopmental disorder.1
387912772024Functional Characterization of a Spectrum of Genetic Variants in a Family with Succinic Semialdehyde Dehydrogenase Deficiency.0
381100412024ALDH5A1-deficient iPSC-derived excitatory and inhibitory neurons display cell type specific alterations.2
386588502024Clinical and molecular outcomes from the 5-Year natural history study of SSADH Deficiency, a model metabolic neurodevelopmental disorder.1
387912772024Functional Characterization of a Spectrum of Genetic Variants in a Family with Succinic Semialdehyde Dehydrogenase Deficiency.0
369764942023Glioma Cells Expressing High Levels of ALDH5A1 Exhibit Enhanced Migration Transcriptional Signature in Patient Tumors.2
379626712023Phenotypic correlates of structural and functional protein impairments resultant from ALDH5A1 variants.5
369764942023Glioma Cells Expressing High Levels of ALDH5A1 Exhibit Enhanced Migration Transcriptional Signature in Patient Tumors.2
379626712023Phenotypic correlates of structural and functional protein impairments resultant from ALDH5A1 variants.5
328810512021ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma.9
333193932021Gene expression analysis in epileptic hippocampi reveals a promoter haplotype conferring reduced aldehyde dehydrogenase 5a1 expression and responsiveness.1
348820732021Assessing Prevalence and Carrier Frequency of Succinic Semialdehyde Dehydrogenase Deficiency.7
328810512021ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma.9
333193932021Gene expression analysis in epileptic hippocampi reveals a promoter haplotype conferring reduced aldehyde dehydrogenase 5a1 expression and responsiveness.1

Citation

Dessen P

ALDH5A1 (aldehyde dehydrogenase 5 family member A1)

Atlas Genet Cytogenet Oncol Haematol. 2018-07-01

Online version: http://atlasgeneticsoncology.org/gene/57398